Liguori Claudio, Frontani Francesco, Francescangeli Giulia, Pierantozzi Mariangela, Cerroni Rocco, Schirinzi Tommaso, Stefani Alessandro, Mercuri Nicola Biagio, Galeoto Giovanni
UOSD Parkinson, Neurology Unit, University Hospital of Rome Tor Vergata, 00133 Rome, Italy.
Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
J Pers Med. 2024 Mar 10;14(3):298. doi: 10.3390/jpm14030298.
Sleep disorders are frequent non-motor symptoms affecting patients with Parkinson's disease (PD). Insomnia represents the most common sleep disorder. Parkinson's disease Sleep Scale 2 (PDSS-2) is a specific tool to investigate sleep problems in PD. The General Sleep Disturbances Scale (GSDS) was a general scale validated for the Italian population. Our goal was to assess the psychometric characteristics of PDSS-2 and the GSDS in this population, calculating a cut-off score for insomnia symptoms by using subitems of PDSS-2.
Patients admitted at the PD Unit of the Hospital of Rome Tor Vergata outpatient clinic and those afferent to PD associations were asked to complete PDSS-2 and GSDS to be correlated to identify a cut-off for insomnia symptoms. Items 1,2,3,8,13 of PDSS-2 were used to detect insomnia. An ROC curve to assess a cut-off score for insomnia was determined. A cross-cultural analysis of PD population characteristics was performed.
In total, 350 PD patients were recruited. Cronbach's alpha was high for the total score (0.828 for PDSS-2 and 0.832 for GSDS). A cross-cultural analysis did not show any significant -value. The ROC curve yielded an AUC of 0.79 (CI: 0.75-0.84). The cut-off value for insomnia disorder based on items 1,2,3,8,13 of PDSS-2 was >10, demonstrating a sensitivity of 76% and a specificity of 69% in determining the presence of subjective insomnia symptoms in PD.
PDSS-2 is demonstrated to be a valid, specific tool to address sleep disturbances in PD patients. A cut-off score of 10 for items 1,2,3,8,13 was identified for detecting insomnia symptoms in PD patients.
睡眠障碍是影响帕金森病(PD)患者的常见非运动症状。失眠是最常见的睡眠障碍。帕金森病睡眠量表2(PDSS - 2)是一种用于调查PD患者睡眠问题的特定工具。一般睡眠障碍量表(GSDS)是一种针对意大利人群验证的通用量表。我们的目标是评估该人群中PDSS - 2和GSDS的心理测量特征,通过使用PDSS - 2的子项目计算失眠症状的临界分数。
邀请罗马第二大学医院门诊PD科收治的患者以及加入PD协会的患者完成PDSS - 2和GSDS,以进行相关性分析,确定失眠症状的临界值。使用PDSS - 2的第1、2、3、8、13项来检测失眠。确定评估失眠临界分数的ROC曲线。对PD人群特征进行跨文化分析。
共招募了350名PD患者。总分的克朗巴哈系数较高(PDSS - 2为0.828,GSDS为0.832)。跨文化分析未显示任何显著的p值。ROC曲线得出的AUC为0.79(CI:0.75 - 0.84)。基于PDSS - 2的第1、2、3、8、13项得出的失眠症临界值>10,在确定PD患者主观失眠症状的存在方面,敏感性为76%,特异性为69%。
PDSS - 2被证明是一种有效的、特定的工具,可用于解决PD患者的睡眠障碍问题。确定PD患者失眠症状的检测临界分数为第1、2、3、8、13项为10。